Intravenous Vitamin C Administration Improved Blood Cell Counts and Health-Related Quality of Life of Patient with History of Relapsed Acute Myeloid Leukaemia
A 52-year-old female presented to Integrated Health Options Clinic in October 2014 with a history of relapsed acute myeloid leukaemia (AML, diagnosed in 2009 and relapsed in 2014). Intravenous(IV) vitamin C therapy was initiated (in 2014) following completion of chemotherapy as an alternative to hae...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-07-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | http://www.mdpi.com/2076-3921/7/7/92 |
_version_ | 1797712413638787072 |
---|---|
author | Mike N. Foster Anitra C. Carr Alina Antony Selene Peng Mike G. Fitzpatrick |
author_facet | Mike N. Foster Anitra C. Carr Alina Antony Selene Peng Mike G. Fitzpatrick |
author_sort | Mike N. Foster |
collection | DOAJ |
description | A 52-year-old female presented to Integrated Health Options Clinic in October 2014 with a history of relapsed acute myeloid leukaemia (AML, diagnosed in 2009 and relapsed in 2014). Intravenous(IV) vitamin C therapy was initiated (in 2014) following completion of chemotherapy as an alternative to haematopoietic stem cell transplantation. IV vitamin C was administered twice weekly at a dose of 70 g/infusion. Within 4 weeks of initiation of IV vitamin C therapy, there was a dramatic improvement in the patient’s blood indices with platelet cell counts increasing from 25 × 109/L to 196 × 109/L and white blood cell counts increasing from 0.29 × 109/L to 4.0 × 109/L, with further improvements observed over the next 18 months. Furthermore, there was a clear and sustained improvement in the patient’s health-related quality of life scores assessed using a validated questionnaire. She has remained healthy and in complete remission until the present day. This case study highlights the benefits of IV vitamin C as a supportive therapy for previously relapsed AML. |
first_indexed | 2024-03-12T07:21:27Z |
format | Article |
id | doaj.art-9c8f98fb549f4c01b64adfa518a0c26b |
institution | Directory Open Access Journal |
issn | 2076-3921 |
language | English |
last_indexed | 2024-03-12T07:21:27Z |
publishDate | 2018-07-01 |
publisher | MDPI AG |
record_format | Article |
series | Antioxidants |
spelling | doaj.art-9c8f98fb549f4c01b64adfa518a0c26b2023-09-02T22:23:25ZengMDPI AGAntioxidants2076-39212018-07-01779210.3390/antiox7070092antiox7070092Intravenous Vitamin C Administration Improved Blood Cell Counts and Health-Related Quality of Life of Patient with History of Relapsed Acute Myeloid LeukaemiaMike N. Foster0Anitra C. Carr1Alina Antony2Selene Peng3Mike G. Fitzpatrick4Integrated Health Options Ltd., Auckland 1050, New ZealandDepartment of Pathology and Biomedical Science, University of Otago, Christchurch 8011, New ZealandFeedback Research Ltd., Auckland 1050, New ZealandFeedback Research Ltd., Auckland 1050, New ZealandFeedback Research Ltd., Auckland 1050, New ZealandA 52-year-old female presented to Integrated Health Options Clinic in October 2014 with a history of relapsed acute myeloid leukaemia (AML, diagnosed in 2009 and relapsed in 2014). Intravenous(IV) vitamin C therapy was initiated (in 2014) following completion of chemotherapy as an alternative to haematopoietic stem cell transplantation. IV vitamin C was administered twice weekly at a dose of 70 g/infusion. Within 4 weeks of initiation of IV vitamin C therapy, there was a dramatic improvement in the patient’s blood indices with platelet cell counts increasing from 25 × 109/L to 196 × 109/L and white blood cell counts increasing from 0.29 × 109/L to 4.0 × 109/L, with further improvements observed over the next 18 months. Furthermore, there was a clear and sustained improvement in the patient’s health-related quality of life scores assessed using a validated questionnaire. She has remained healthy and in complete remission until the present day. This case study highlights the benefits of IV vitamin C as a supportive therapy for previously relapsed AML.http://www.mdpi.com/2076-3921/7/7/92vitamin Cintravenous vitamin Cleukemiaacute myeloid leukemiaAML |
spellingShingle | Mike N. Foster Anitra C. Carr Alina Antony Selene Peng Mike G. Fitzpatrick Intravenous Vitamin C Administration Improved Blood Cell Counts and Health-Related Quality of Life of Patient with History of Relapsed Acute Myeloid Leukaemia Antioxidants vitamin C intravenous vitamin C leukemia acute myeloid leukemia AML |
title | Intravenous Vitamin C Administration Improved Blood Cell Counts and Health-Related Quality of Life of Patient with History of Relapsed Acute Myeloid Leukaemia |
title_full | Intravenous Vitamin C Administration Improved Blood Cell Counts and Health-Related Quality of Life of Patient with History of Relapsed Acute Myeloid Leukaemia |
title_fullStr | Intravenous Vitamin C Administration Improved Blood Cell Counts and Health-Related Quality of Life of Patient with History of Relapsed Acute Myeloid Leukaemia |
title_full_unstemmed | Intravenous Vitamin C Administration Improved Blood Cell Counts and Health-Related Quality of Life of Patient with History of Relapsed Acute Myeloid Leukaemia |
title_short | Intravenous Vitamin C Administration Improved Blood Cell Counts and Health-Related Quality of Life of Patient with History of Relapsed Acute Myeloid Leukaemia |
title_sort | intravenous vitamin c administration improved blood cell counts and health related quality of life of patient with history of relapsed acute myeloid leukaemia |
topic | vitamin C intravenous vitamin C leukemia acute myeloid leukemia AML |
url | http://www.mdpi.com/2076-3921/7/7/92 |
work_keys_str_mv | AT mikenfoster intravenousvitamincadministrationimprovedbloodcellcountsandhealthrelatedqualityoflifeofpatientwithhistoryofrelapsedacutemyeloidleukaemia AT anitraccarr intravenousvitamincadministrationimprovedbloodcellcountsandhealthrelatedqualityoflifeofpatientwithhistoryofrelapsedacutemyeloidleukaemia AT alinaantony intravenousvitamincadministrationimprovedbloodcellcountsandhealthrelatedqualityoflifeofpatientwithhistoryofrelapsedacutemyeloidleukaemia AT selenepeng intravenousvitamincadministrationimprovedbloodcellcountsandhealthrelatedqualityoflifeofpatientwithhistoryofrelapsedacutemyeloidleukaemia AT mikegfitzpatrick intravenousvitamincadministrationimprovedbloodcellcountsandhealthrelatedqualityoflifeofpatientwithhistoryofrelapsedacutemyeloidleukaemia |